JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROBBINS, B. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by ROBBINS, B. H.
Journal of Pharmacology And Experimental Therapeutics, Vol. 58, Issue 3, 243-250, 1936
Copyright © 1936 by American Society for Pharmacology and Experimental Therapeutics


STUDIES OF CYCLOPROPANE I. THE QUANTITATIVE DETERMINATION OF CYCLOPROPANE IN AIR, WATER, AND BLOOD BY MEANS OF IODINE PENTOXIDE

BENJAMIN H. ROBBINS 1

1 From the Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee

1. The iodine pentoxide train has been adapted for the analysis of cyclopropane.

2. Cyclopropane in air, water, and blood has been determined by the iodine pentoxide method.

3. The distribution ratio of cyclopropane between water and air over a temperature range of 20° to 45° has been determined.

4. The distribution ratio of cyclopropane between blood and air over a temperature range of 20° to 40° has been determined.

5. The solubility of cyclopropane in both human and dog blood is about two and one-half times as great as its solubility in water at corresponding temperatures and pressure.1

Submitted on June 29, 1936







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1936 by the American Society for Pharmacology and Experimental Therapeutics.